Xeris Pharmaceuticals Inc (XERS) — Financial Flexibility Index
Xeris Pharmaceuticals Inc (XERS) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of $20.38 Million (operating CF $20.04 Million minus capex $333.00K) represents 0% of total liabilities ($369.84 Million). Also explore XERS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xeris Pharmaceuticals Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Xeris Pharmaceuticals Inc across 10 annual periods. Check Xeris Pharmaceuticals Inc (XERS) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Xeris Pharmaceuticals Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Xeris Pharmaceuticals Inc. For the full company profile including market capitalisation, see Xeris Pharmaceuticals Inc (XERS) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | $29.32 Million | $28.63 Million | $369.84 Million | ▲ +177.4% |
| 2024 | -0.10x | $-36.11 Million | $-36.98 Million | $352.68 Million | ▲ +24.6% |
| 2023 | -0.14x | $-44.76 Million | $-47.02 Million | $329.38 Million | ▲ +60.3% |
| 2022 | -0.34x | $-102.37 Million | $-102.89 Million | $299.33 Million | ▲ +24.3% |
| 2021 | -0.45x | $-94.45 Million | $-95.53 Million | $209.13 Million | ▲ +46.7% |
| 2020 | -0.85x | $-80.18 Million | $-80.56 Million | $94.55 Million | ▲ +22.3% |
| 2019 | -1.09x | $-103.24 Million | $-104.35 Million | $94.55 Million | ▲ +11.0% |
| 2018 | -1.23x | $-54.77 Million | $-56.28 Million | $44.62 Million | ▼ -426.7% |
| 2017 | -0.23x | $-23.96 Million | $-24.66 Million | $102.83 Million | ▲ +5.0% |
| 2016 | -0.25x | $-16.05 Million | $-16.09 Million | $65.47 Million | — |